Prof Lynda Wyld speaks to ecancer about her presentation at the EBCC 2020 online congress.
She speak about the age-gap study which has been running since 2013, designed to understand if primary endocrine therapy (omitting surgery) was safe for older women with breast cancer.
Prof Wyld spoke about the design of the trial, and analysed some of the results. She also discussed how quality of life was taken into account when looking at the decision making process for surgery.